JUNGLE TAX
Founder & Business Exit Tax19 September 2026·13 min read

Specialist US UK Tax Services: Patent Box on a US Return

Specialist US UK tax services for American founders: how a UK Patent Box claim cuts UK tax to 10% yet can trigger a current US inclusion. Speak to our team.

Specialist US UK tax services for American owners of UK Patent Box companies reporting relevant IP profits on Form 5471 | Jungle Tax
Founder & Business Exit Tax

A 10% UK rate on IP profits can be the very thing that triggers a US inclusion.

Natural voice · plays in your browser

A UK company that has elected into the Patent Box pays an effective 10% corporation tax rate on qualifying IP profits. For an American owner that relief is not free: it lowers the UK effective rate used to test the high-tax exclusion, and can convert sheltered foreign profits into a current US inclusion. Specialist US UK tax services exist for this collision.

What the Patent Box actually does to a UK company's corporation tax

The Patent Box applies an effective 10% corporation tax rate to profits attributable to qualifying patents, measured against a 25% main rate for companies above the upper profits limit. Two features of the regime are routinely misunderstood on the American side of a cross-border file, and both matter for the US return.

First, it is not a headline rate reduction. The company does not file its return at 10%. It computes its profits in the ordinary way and then claims an additional trading deduction, calculated by formula, which reduces taxable profit to the point where the main rate applied to the reduced figure produces the same tax as 10% applied to the relevant IP profits. Second, it is not a credit, a grant or a receipt. Nothing is paid to the company. That distinction is what separates this relief from the R&D regime, and it drives an entirely different US analysis.

Jungle Tax prepares the US and UK sides of these files together, because the UK computation is an input to the US return rather than a separate exercise that happens to run in parallel.

Which companies and which rights qualify

The company must be within the charge to UK corporation tax and must earn profits from exploiting qualifying IP rights that it owns or exclusively licenses in. Qualifying rights are principally patents granted by the UK Intellectual Property Office, by the European Patent Office, or by the patent offices of specified European Economic Area states whose examination standards are treated as equivalent. Certain supplementary protection certificates, plant variety rights and regulatory data protection rights also qualify. Registered designs, trade marks, copyright and unpatented know-how do not.

An exclusive licence must confer exclusivity across at least an entire national territory and must include the right to bring infringement proceedings or to receive damages. Partial or field-limited licences frequently fail this test, and where they fail, the income they generate never enters the calculation at all.

Qualifying development and active ownership

The company, or a member of its group, must have undertaken qualifying development: a significant contribution to the creation or development of the patented invention, or to a product incorporating it. Where the claim is made by a group company that did not itself carry out that development, the active ownership condition additionally requires it to perform a significant management role across the portfolio of eligible rights. HMRC publishes the operative guidance on eligibility and claim mechanics in its Patent Box guidance.

The election and its two-year time limit

Relief is not automatic. The company must elect in, and the election must be made within two years after the end of the accounting period in which the relevant profits and income arose. It may be delivered with the tax computations or separately in writing. Once made, the election covers all qualifying IP income of the trade; it cannot be cherry-picked right by right. It continues until revoked, and revocation carries a lock-out period before the company can elect in again.

For an American founder, the two-year window has a second significance that UK-only material never mentions. A late election, or an amended return that brings a prior period into the regime, retrospectively changes the UK effective tax rate for a year whose US return has already been filed. That is a US amendment question, not merely a UK one.

How relevant IP profits are computed under the nexus regime

The calculation is a sequence, and each step removes something. Understanding the sequence is necessary because the US return needs the rate at the end of it, not the headline 10%.

Streaming and sub-streams

Under the modified regime that now applies to all claimants, streaming is mandatory rather than elective. The company allocates its trading income to relevant IP income sub-streams, typically one per qualifying right or per product family covered by a right, and allocates expenditure across those sub-streams on a just and reasonable basis. Each sub-stream then carries its own calculation to the end. HMRC's relevant IP profits guidance sets out the statutory steps.

Relevant IP income: what goes into the stream

  • Worldwide sales of items protected by a qualifying right, and of items incorporating such an item
  • Sales of bespoke spare parts designed for a protected item
  • Licence fees and royalties from granting rights over qualifying IP
  • Proceeds of sale or other disposal of a qualifying right or an exclusive licence
  • Infringement damages, compensation and insurance proceeds referable to a qualifying right
  • A notional royalty where the company exploits the invention in its own process rather than selling protected items

Income from non-qualifying activity, finance income and, critically, income attributable to brand rather than patent, is excluded at one step or another. A software business with a single granted patent covering one module cannot sweep its whole subscription line into the box.

The routine return deduction

The regime assumes that a business earns a baseline return from its routine functions regardless of any unique IP. That baseline is removed by deducting 10% of specified routine expenditure, broadly capital allowances, premises costs, personnel costs, plant and machinery costs, professional services and miscellaneous services. Certain items are expressly not routine deductions, including R&D expenditure itself and loan relationship debits. What remains after the routine return is stripped out is the qualifying residual profit.

The marketing assets return deduction

The qualifying residual profit still contains value attributable to brand and marketing assets, and that value is not intended to receive the reduced rate. The company deducts a marketing assets return, computed as the notional marketing royalty the business would pay for its brand less any actual marketing royalty already paid. Where the marketing assets return is small relative to the qualifying residual profit, it can be disregarded, and companies below the statutory thresholds may instead elect small claims treatment, which substitutes a formulaic figure for the full marketing assets computation.

The R&D fraction

Finally the nexus rule applies. Each sub-stream's relevant IP profit is multiplied by an R&D fraction that compares the company's own qualifying development spend and third-party subcontracted spend against acquisition costs and related-party subcontracting, with a 30% uplift on the qualifying numerator, capped at one. A company that developed its patents in-house typically carries a fraction of one. A company that acquired its patents, or that subcontracted development to a connected party, will see the benefit cut proportionately. The fraction is tracked cumulatively, which is why sub-stream records must be carried forward year on year.

How the 10% is delivered

Relief is given as an additional trading deduction, computed by applying a statutory formula to the relevant IP profits figure. The deduction is the relevant IP profits multiplied by the difference between the main rate and 10%, divided by the main rate. At a 25% main rate that is 60% of the relevant IP profits. The company's taxable profit falls by that amount; the corporation tax charge falls accordingly; the resulting effective rate on the IP profits is 10%. Nothing in the return says "10%", which is precisely why a US preparer reading only the headline rate will get the effective-rate test wrong.

Why this lands on the US return: the CFC collision

Here is the point of this guide, and the point no UK-only page covers. The relief that made the UK bill smaller is capable of making the US bill larger.

Is the UK company a controlled foreign corporation?

A foreign corporation is a CFC where US shareholders, meaning US persons each owning 10% or more of vote or value, together own more than 50%. A founder-owned UK company with an American at the top is almost always a CFC. Attribution rules mean a minority American holder can be caught where family or entity attribution aggregates the interest. Being a CFC shareholder brings annual Form 5471 reporting and exposure to current inclusions on undistributed profits.

The high-tax exclusion, and how Patent Box can cost you it

Tested income that has borne a sufficiently high effective foreign tax rate can be excluded from the tested income regime altogether. The threshold is 90% of the maximum US corporate rate, which at a 21% corporate rate is 18.9%. The test is applied at tested unit level, using the foreign taxes properly attributable to the tested unit's income as determined under US principles, not the UK computation.

A UK company paying 25% on everything clears that bar with room to spare, and for many American founders that has been the quiet reason their UK trading profits never appeared on a US return. Introduce a Patent Box claim and the arithmetic moves. If a substantial share of the company's profits are qualifying IP profits taxed at an effective 10%, the blended effective rate of the tested unit can fall below 18.9%. The exclusion is then unavailable for that unit, and the profits are picked up as a current inclusion on the American shareholder's Form 1040, in a year when no dividend has been paid.

The proportions decide it. A company where qualifying IP profits are a modest slice of the whole may still blend above the threshold. A company whose profits are overwhelmingly patent-derived almost certainly will not. This has to be computed, with the streaming workings in hand, before the US return is signed.

What changed for 2026

For tax years beginning after 31 December 2025 the regime is recast. Tested income is now described as net CFC tested income, the deduction available against it is reduced from 50% to 40%, the deemed-paid credit haircut is reduced from 20% to 10%, and the 10% return on qualifying business asset investment is eliminated. The practical effect for a Patent Box company is twofold: the US cost of losing the exclusion is higher than it was, because the pre-credit effective rate on an inclusion has risen; and there is no longer an asset-based carve-out to absorb part of the tested income before it is taxed. Read alongside our guide on inclusions for US founders of UK limited companies, which sets out the base computation this article builds on. The Form 8992 guidance carries the current shareholder-level computation.

Tested income, earnings and profits, and the Form 5471 computation

This is where the additional trading deduction has to be handled correctly, and where we see the most errors on returns prepared without UK input.

Earnings and profits and tested income are computed under US tax principles, starting from the accounts and adjusting. A UK statutory deduction that has no US analogue, and that corresponds to no economic outlay, is not respected as an expense for that purpose. The additional trading deduction therefore does not reduce tested income. What does reduce both earnings and profits and tested income is the UK corporation tax accrued, and the claim has made that smaller. The net result of a successful Patent Box claim is usually higher US tested income and higher earnings and profits than an unadjusted reading of the UK computation would suggest, alongside a lower pool of foreign tax.

Two figures therefore move in the wrong direction at once: more income in the US measure, less foreign tax to set against it.

Does UK corporation tax reduced by a Patent Box claim still support a foreign tax credit?

Yes. The relief is a reduction in the amount of tax imposed, not a subsidy, a rebate or a payment from government, so the UK corporation tax actually paid remains a creditable income tax. There is no principle that disqualifies the residual tax because a statutory deduction reduced it.

The limitation is simply quantitative. If the UK charge has fallen by 60% of the relevant IP profits multiplied by the main rate, the credit pool has fallen by the same amount. Companies sometimes assume that a reduced UK bill is neutral because "the credit covers it anyway". Where an inclusion arises, it does not.

As to basket, taxes attributable to tested income go into the tested income basket, which is a separate limitation category with no carryback and no carryforward. Excess credits there are simply lost. Taxes on other categories of the company's income follow their own baskets, and an individual claiming credits directly reports them on the individual foreign tax credit form. Where an inclusion arises in a year with a stranded tested income basket, the practical answer is usually found in the election discussed next rather than in the credit rules themselves.

What difference does a section 962 election make?

An individual US shareholder, absent an election, is taxed on an inclusion at ordinary individual rates and cannot claim deemed-paid credits for the foreign taxes the company paid. That is the worst possible interaction with a Patent Box claim: full inclusion, top individual rate, no company-level credit.

A section 962 election treats the individual, for the limited purpose of the inclusion, as though a domestic corporation stood in the chain. The inclusion is taxed at the corporate rate, the deduction against net CFC tested income becomes available, and deemed-paid credits for the company's foreign taxes come into play subject to the statutory haircut. For a company whose effective UK rate has been reduced to somewhere between 10% and 18.9%, the election frequently moves the current-year cost from painful to modest.

The cost is deferred, not removed. Distributions later received out of the same earnings are generally taxable again to the extent they exceed the tax paid under the election, and the analysis of whether a UK distribution is a qualified dividend has to be made on its own terms. The election is annual and must be documented with the required statement.

IssueUK treatment (HMRC)US treatment (IRS)
Form of the reliefAdditional trading deduction reducing taxable profitNot recognised; no US deduction analogue
Effective rate on IP profits10% on relevant IP profitsUsed as an input to the high-tax effective rate test
Effect on the profit measureReduces UK taxable profitNo reduction to earnings and profits or tested income
Effect on tax paidReduces the corporation tax chargeReduces creditable foreign tax and lowers earnings and profits
Consequence for the ownerNone; relief sits at company levelMay forfeit the high-tax exclusion and create a current inclusion
Election deadlineTwo years from the end of the accounting periodAnnual elections filed with the shareholder's return

Patent Box and R&D credits are two different US problems

These reliefs are often discussed together in UK material because the same companies claim both, but their US consequences have almost nothing in common. Our companion guide on UK R&D credits on a US return deals with a receipt: an above-the-line credit arrives, and the question is how to characterise it in the US accounts and computation. This guide deals with the opposite shape of problem: nothing arrives, and the question is what a reduced rate on output profits does to effective-rate testing. Read as a pair, they cover the two ends of a UK innovation-relief file.

FeatureUK R&D expenditure creditUK Patent Box
What the company receivesA taxable above-the-line creditNothing; a lower tax charge only
Where it appliesInput costs of developmentOutput profits from exploiting patents
Primary US questionCharacterisation of the receiptEffect on the effective foreign tax rate
Typical US riskUnderstated tested incomeLoss of the high-tax exclusion

Preparing the US return for a Patent Box year

Where the claim has already been made, the US compliance sequence is mechanical, provided the UK workings are available.

  • Obtain the statutory accounts and the full corporation tax computation, including the Patent Box schedule and the additional deduction formula as applied
  • Obtain the streaming analysis by sub-stream, with the routine return and marketing assets return workings and the R&D fraction calculation
  • Identify the tested units and allocate income and foreign tax to each under US principles
  • Compute earnings and profits and tested income from the accounts, without importing the UK additional deduction
  • Test each tested unit's effective foreign rate against the 18.9% threshold and document the result either way
  • Where the exclusion is unavailable, compute the inclusion, then model the position with and without a section 962 election
  • Confirm the UK tax actually paid and the payment dates, and place the credits in the correct limitation categories
  • Complete the Form 5471 schedules consistently with the inclusion position taken

Our US UK tax accountants run this sequence as a single file rather than two, and our wider US tax services cover the shareholder-level filings that follow from it.

Errors we see on filed returns

  • Treating the 25% headline rate as the effective rate and concluding the exclusion applies without computing anything
  • Deducting the additional trading deduction in the earnings and profits computation, understating both earnings and profits and tested income
  • Testing at company level rather than tested unit level, masking a sub-threshold unit inside a blended average
  • Claiming a credit for UK tax that the Patent Box claim means was never paid
  • Filing without any documentation of the streaming analysis, leaving the effective rate unevidenced if the return is examined
  • Amending a UK return into the regime within the two-year window and never revisiting the US return for the same year
  • Assuming the position is unchanged year to year, when the R&D fraction and the sub-stream mix both move

If prior years were filed on any of these assumptions, the position is usually correctable. Where US returns were not filed at all, our streamlined filing work addresses the catch-up, and the full library sits in our guides.

Speak to us in confidence

If your UK company has elected into the Patent Box and you hold US shares in it, the effective rate on your qualifying IP profits is now a number your US return depends on. We prepare both computations together, evidence the effective rate of each tested unit, and file the shareholder position that follows. To review a Patent Box year before it is filed, or to correct one that has already been filed, contact our cross-border team for a confidential consultation.

Speak to a specialist

Need help with founder & business exit tax?

Jungle Tax advises high-net-worth individuals and businesses across the US and UK. Book a confidential consultation and we will map your position on both sides of the Atlantic.

Jungle Tax home · All expert guides · Business & Corporate Tax Planning

■ FREQUENTLY ASKEDQUESTIONS

Questions & Answers

No. The Patent Box is a UK corporation tax relief claimed by the company. It reduces UK tax on qualifying IP profits to an effective 10% rate but has no direct effect on a US shareholder's liability. Its indirect effect runs the other way: by lowering the UK effective rate, it can remove an exclusion that previously kept those profits off the US return entirely.

Yes, and this is the central risk. Where a UK company's profits were previously shielded because UK tax exceeded the high-tax threshold, a Patent Box claim can push the tested unit's effective rate below it. The exclusion is then unavailable and the tested income flows through to the US shareholder as a current inclusion, even though not a penny has been distributed.

The exclusion applies where the tested unit's effective foreign rate exceeds 90% of the maximum US corporate rate. With a 21% corporate rate that threshold is 18.9%. A UK company paying 25% clears it comfortably. A UK company whose qualifying IP profits sit at an effective 10% may not, and blended rates across the whole tested unit must be computed rather than assumed.

Yes, but only for tax actually paid. A Patent Box claim reduces the UK liability, so the creditable amount falls with it. The relief is not a refundable credit or a government grant, so it does not create a separate item of income. What it does is shrink the pool of foreign tax available to offset any US inclusion arising on the same profits.

It is not a separate line. The additional trading deduction reduces UK taxable profit, and the UK tax charge that results feeds the income statement and the tax schedules. Earnings and profits and tested income are computed under US principles from the accounts, not from the UK computation, so the deduction affects the tax figures rather than the underlying profit measure.

It can. The election taxes the inclusion at corporate rates and opens access to deemed-paid credits for the company's foreign taxes, which an individual shareholder otherwise cannot claim. The trade-off is that later actual distributions above the tax already paid are generally taxable again. The arithmetic depends heavily on how far the Patent Box has reduced the UK tax available to credit.

The election must be made within two years after the end of the accounting period in which the relevant profits and income arose. It can be submitted with the tax computations or separately in writing. Once made, it applies to all qualifying IP income of the trade, and it continues until revoked, with a lock-out period following revocation.

No, and conflating them is a common error. An above-the-line R&D credit is a receipt that must be characterised, most often as an item reducing expense or increasing income. The Patent Box gives no receipt at all. It reduces the rate borne on output IP profits, so its US consequence is felt in effective-rate testing rather than in characterisation.

Not directly. Earnings and profits are computed under US tax principles, and a UK-specific statutory deduction is not respected as an expense for that purpose. What does reduce earnings and profits is the UK corporation tax actually accrued, which the claim has lowered. The net effect is usually higher earnings and profits, not lower, than the UK computation would suggest.

The statutory accounts, the full UK corporation tax computation including the Patent Box schedule, the streaming and sub-stream analysis, the routine return and marketing assets return workings, the R&D fraction calculation, and the UK tax actually paid with payment dates. Without the streaming detail the effective rate of each tested unit cannot be evidenced on the US return.

Still have questions? We're here to help.

Get in Touch

Official resources & further reading

Authoritative guidance from the relevant tax authorities and regulators. Always confirm current thresholds and deadlines on the official source.